Search

Medtronic PLC

Fermé

SecteurSoins de santé

88.53 0.06

Résumé

Variation du prix de l'action

24h

Actuel

Min

87.11

Max

88.97

Chiffres clés

By Trading Economics

Revenu

206M

1.5B

Ventes

-51M

9.8B

P/E

Moyenne du Secteur

22.599

55.725

BPA

1.45

Rendement du dividende

3.09

Marge bénéficiaire

15.16

Employés

95,000

EBITDA

-682M

2B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+16.84% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

3.09%

2.25%

Prochains Résultats

17 nov. 2026

Date du Prochain Dividende

16 oct. 2026

Date du Prochain Détachement de Dividende

25 sept. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.3B

117B

Ouverture précédente

88.47

Clôture précédente

88.53

Sentiment de l'Actualité

By Acuity

37%

63%

72 / 339 Classement par Healthcare

Medtronic PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 sept. 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 sept. 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 sept. 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 sept. 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

17 sept. 2026, 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

16 sept. 2026, 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

15 sept. 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

14 sept. 2026, 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

11 sept. 2026, 22:52 UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

10 sept. 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

9 sept. 2026, 22:02 UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

8 sept. 2026, 23:01 UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

4 sept. 2026, 23:16 UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

3 sept. 2026, 23:01 UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2 sept. 2026, 23:06 UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 sept. 2026, 23:06 UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

31 août 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

29 août 2026, 00:06 UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

28 août 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

27 août 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

26 août 2026, 23:02 UTC

Event

Medtronic PLC shares are lower in after-market hours as investors adjust ahead of the Q1 FY2027 earnings announcement, estimating EPS at $1.39.

25 août 2026, 23:02 UTC

Medtronic PLC shares are higher in after-market hours amid a positive market response to falling crude oil prices following U.S. sanctions against Iran.

24 août 2026, 23:26 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects concerns over U.S. sanctions on Iran.

22 août 2026, 00:02 UTC

Medtronic PLC shares are lower in after-market trading, continuing a decline since Friday's close, despite broader gains in the health care equipment sector.

21 août 2026, 23:01 UTC

Medtronic PLC shares are trading lower in after-market hours, though they remain above the 20-day moving average and near the upper end of their one-month range.

20 août 2026, 19:56 UTC

News

Medtronic PLC shares are lower today amid broader market pressures and concerns about consumer spending following Walmart's significant decline.

19 août 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market trading, showing unusual weakness despite being above its 20-day moving average and near the upper end of its one-month range.

18 août 2026, 23:01 UTC

Medtronic PLC shares are slightly higher in after-market hours. The stock remains above its 20-day moving average amid broader market concerns over rising Treasury yields.

17 août 2026, 20:07 UTC

Social Media

Medtronic PLC shares are lower amid discussions of a potential AVR acquisition. Broader economic concerns include a significant drop in U.S. retail sales.

14 août 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

Comparaison

Variation de prix

Medtronic PLC prévision

Objectif de Prix

By TipRanks

16.84% hausse

Prévisions sur 12 Mois

Moyen 103.412 USD  16.84%

Haut 118 USD

Bas 85 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

20 ratings

12

Achat

8

Maintien

0

Vente

Sentiment

By Acuity

72 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.